reserpine has been researched along with Movement Disorders in 95 studies
Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tetrabenazine (TBZ) is a monoamine-depleting agent initially studied in the 1950s and currently approved by the US Food and Drug Administration for the treatment of chorea in Huntington's disease." | 6.46 | Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. ( Guay, DR, 2010) |
| "Reserpine treatment increased VCMs and decreased locomotor activity." | 5.39 | Effect of Hypericum perforatum on different models of movement disorders in rats. ( Athayde, ML; Boligon, AA; Busanello, A; Fachinetto, R; Leal, CQ; Reckziegel, P; Reis, EM; Röpke, J; Wagner, C, 2013) |
| "This is a review of reserpine, haloperidol, and various phenothiazines that produce parkinsonism and other movement disorders." | 4.78 | Drug-induced parkinsonism and other movement disorders. ( Ross, RT, 1990) |
| " The mothers of three infants had been on medication (either alpha-methyl dopa, reserpine or haloperidol) during pregnancy, whereas the mothers of the other three infants took no medication during pregnancy." | 3.71 | Rapid-eye-movement sleep in jittery infants. ( Iwakawa, Y; Kohyama, J; Shimohira, M, 2002) |
| "Tetrabenazine (TBZ) is a monoamine-depleting agent initially studied in the 1950s and currently approved by the US Food and Drug Administration for the treatment of chorea in Huntington's disease." | 2.46 | Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. ( Guay, DR, 2010) |
| "Reserpine treatment (1mg/kgs." | 1.42 | (-) Epigallocatechin-3-gallate attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. ( Chang, KC; Lin, RF; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH, 2015) |
| "Reserpine treatment increased VCMs and decreased locomotor activity." | 1.39 | Effect of Hypericum perforatum on different models of movement disorders in rats. ( Athayde, ML; Boligon, AA; Busanello, A; Fachinetto, R; Leal, CQ; Reckziegel, P; Reis, EM; Röpke, J; Wagner, C, 2013) |
| "Here we used the animal models of extrapyramidal disorders cited above, which were performed in two distinct experiments: orofacial dyskinesia (OD)/catalepsy induced by acute reserpine and subchronic haloperidol after (experiment 1) and before (experiment 2) oral treatment with pecan shell aqueous extract (AE), a natural and promissory antioxidant." | 1.37 | Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract. ( Barcelos, RC; Benvegnú, DM; Boufleur, N; Bürger, ME; Dias, VT; Dolci, GS; Pase, CS; Reckziegel, P; Segat, HJ; Trevizol, F, 2011) |
| "Reserpine treated rats significantly developed vacuous chewing movements and tongue protrusions however, coadministration of Hibiscus rosa sinensis roots extract (100, 200 and 300 mg/kg, per orally) attenuated the effects." | 1.35 | Effect of Hibiscus rosa sinensis on reserpine-induced neurobehavioral and biochemical alterations in rats. ( Dwivedi, S; Kawale, LA; Nade, VS; Upasani, CD; Yadav, AV, 2009) |
| " The ip LD50 of CPA was found to be 13 +/- 0." | 1.27 | Toxicity and neuropharmacology of cyclopiazonic acid. ( Cole, RJ; Dorner, JW; Nishie, K, 1985) |
| "The syndrome was not seen after thioridazine (3-7 mg/kg)." | 1.26 | Acute dystonia as an idiosyncratic response to neuroleptics in baboons. ( Anlezark, GM; Marsden, CD; Meldrum, BS, 1977) |
| " The main metabolite of piribedil, S 584, had no clear-cut pharmacologic action in our hands at the dosage used." | 1.25 | Apomorphine and piribedil in rats: biochemical and pharmacologic studies. ( Barbeau, A; Butterworth, RF; Poignant, JC, 1975) |
| "Reserpine pretreatment potentiates turning produced by (-)-ephedrine." | 1.25 | Turning behaviour as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones. ( Christie, JE; Crow, TJ, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 81 (85.26) | 18.7374 |
| 1990's | 2 (2.11) | 18.2507 |
| 2000's | 5 (5.26) | 29.6817 |
| 2010's | 7 (7.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reis, EM | 1 |
| Röpke, J | 1 |
| Busanello, A | 1 |
| Reckziegel, P | 3 |
| Leal, CQ | 1 |
| Wagner, C | 1 |
| Boligon, AA | 1 |
| Athayde, ML | 1 |
| Fachinetto, R | 1 |
| Wang, MH | 1 |
| Lin, RF | 1 |
| Tseng, HC | 1 |
| Soung, HS | 1 |
| Chang, KC | 1 |
| Tsai, CC | 1 |
| Kronbauer, M | 1 |
| Segat, HJ | 2 |
| De David Antoniazzi, CT | 1 |
| Roversi, K | 2 |
| Pase, CS | 2 |
| Barcelos, RC | 3 |
| Burger, ME | 3 |
| Aguiar, AS | 1 |
| Araújo, AL | 1 |
| da-Cunha, TR | 1 |
| Speck, AE | 1 |
| Ignácio, ZM | 1 |
| De-Mello, N | 1 |
| Prediger, RD | 1 |
| Nade, VS | 1 |
| Dwivedi, S | 1 |
| Kawale, LA | 1 |
| Upasani, CD | 1 |
| Yadav, AV | 1 |
| Guay, DR | 1 |
| Benvegnú, DM | 2 |
| Boufleur, N | 2 |
| Pase, C | 1 |
| Teixeira, AM | 1 |
| Emanuelli, T | 1 |
| da Rocha, JB | 1 |
| Trevizol, F | 1 |
| Dias, VT | 1 |
| Dolci, GS | 1 |
| Maxia, A | 1 |
| Frau, MA | 1 |
| Foddis, C | 1 |
| Lancioni, MC | 1 |
| Kasture, V | 1 |
| Kasture, S | 1 |
| FLUGEL, F | 2 |
| BOURGUIGNON, A | 2 |
| DELAY, J | 2 |
| DENIKER, P | 2 |
| LEMPERIERE, T | 2 |
| GERSTENBRAND, F | 3 |
| WEINGARTEN, K | 2 |
| WINDLE, WF | 1 |
| CAMMERMEYER, J | 1 |
| JORALEMON, J | 1 |
| SMART, JO | 1 |
| FERINGA, ER | 1 |
| MCQUILLEN, MP | 1 |
| DE NEGRI, M | 1 |
| GRILLO, V | 1 |
| STREHL, W | 1 |
| HAASE, HJ | 1 |
| KORANYI, L | 1 |
| ENDROECZI, E | 1 |
| LISSAK, K | 1 |
| MARKHAM, CH | 1 |
| CLARK, WG | 1 |
| WINTERS, WD | 1 |
| PROSENZ, P | 1 |
| HAEFNER, H | 1 |
| KUTSCHER, I | 1 |
| ROOS, BE | 1 |
| STEG, G | 3 |
| ZSCHUCKE, CF | 1 |
| HUNTER, R | 1 |
| EARL, CJ | 1 |
| THRONICROFT, S | 1 |
| BOZZI, R | 1 |
| BRUNO, A | 1 |
| ALLEGRANZA, A | 1 |
| Kovoor, A | 1 |
| Seyffarth, P | 1 |
| Ebert, J | 1 |
| Barghshoon, S | 1 |
| Chen, CK | 1 |
| Schwarz, S | 1 |
| Axelrod, JD | 1 |
| Cheyette, BN | 1 |
| Simon, MI | 1 |
| Lester, HA | 1 |
| Schwarz, J | 1 |
| Scheel-Krüger, J | 1 |
| Randrup, A | 1 |
| Chadha, A | 1 |
| Sur, C | 1 |
| Atack, J | 1 |
| Duty, S | 1 |
| Shimohira, M | 1 |
| Iwakawa, Y | 1 |
| Kohyama, J | 1 |
| Paulson, G | 1 |
| Meldrum, BS | 1 |
| Anlezark, GM | 1 |
| Marsden, CD | 6 |
| Pappenheim, E | 1 |
| Vigouret, JM | 1 |
| Bürki, HR | 1 |
| Jaton, AL | 1 |
| Züger, PE | 1 |
| Loew, DM | 1 |
| Obeso, JA | 1 |
| Marti-Masso, JF | 1 |
| Astudillo, W | 1 |
| de la Puente, E | 1 |
| Carrera, N | 1 |
| Poirier, LJ | 3 |
| Péchadre, JC | 1 |
| Larochelle, L | 3 |
| Dankova, J | 1 |
| Boucher, R | 2 |
| Dolphin, A | 2 |
| Jenner, P | 3 |
| Butterworth, RF | 1 |
| Poignant, JC | 1 |
| Barbeau, A | 1 |
| Stimmel, GL | 1 |
| Clyne, KE | 1 |
| Juhl, R | 1 |
| Popoli, P | 1 |
| Caporali, MG | 1 |
| Scotti de Carolis, A | 1 |
| Ross, RT | 1 |
| Cooper, DR | 1 |
| Marrel, C | 1 |
| van de Waterbeemd, H | 1 |
| Testa, B | 1 |
| Frances, H | 1 |
| Bulach, C | 1 |
| Simon, P | 1 |
| Fillion, M | 1 |
| Fillion, G | 1 |
| Colpaert, FC | 1 |
| Nishie, K | 1 |
| Cole, RJ | 1 |
| Dorner, JW | 1 |
| Villeneuve, A | 3 |
| Böszörményi, Z | 2 |
| Langelier, P | 1 |
| Bédard, P | 2 |
| Parent, A | 1 |
| Roberge, AG | 1 |
| Birkmayer, W | 1 |
| Curzon, G | 1 |
| Jurna, I | 4 |
| Lanzer, G | 1 |
| Müller-Calgan, H | 1 |
| Sommer, S | 1 |
| Theres, C | 1 |
| Bachmann, T | 1 |
| Hartmann-von Monakow, K | 1 |
| Constantinidis, J | 1 |
| Ungerstedt, U | 1 |
| Chase, TN | 1 |
| Divac, I | 1 |
| Ditfurth, HV | 1 |
| Aceto, MD | 1 |
| Harris, LS | 1 |
| Lesher, GY | 1 |
| Pearl, J | 1 |
| Brown, TG | 1 |
| Turunen, S | 1 |
| Achté, KA | 1 |
| Sourkes, TL | 1 |
| Gordon, N | 1 |
| Bordeleau, JM | 1 |
| Tétreault, L | 1 |
| Crane, GE | 2 |
| Wolf, SM | 1 |
| Duvoisin, RC | 3 |
| Tarsy, D | 1 |
| Millichap, JG | 1 |
| Fowler, GW | 1 |
| Mones, RJ | 1 |
| Peters, HA | 1 |
| Daly, RF | 1 |
| Sato, S | 2 |
| Degkwitz, R | 1 |
| North, RR | 1 |
| Boggan, WO | 1 |
| Seiden, LS | 1 |
| Daly, R | 1 |
| Peters, H | 1 |
| Christie, JE | 1 |
| Crow, TJ | 1 |
| Ericsson, AD | 2 |
| Wertman, BG | 2 |
| Duffy, KM | 1 |
| Himwich, WA | 2 |
| Goldstein, SL | 1 |
| Fox, MW | 1 |
| Rovine, BW | 1 |
| Goldstein, S | 1 |
| Leiner, K | 1 |
| Stout, M | 1 |
| Kato, T | 1 |
| Yoshioka, T | 1 |
| Tauchi, K | 1 |
| Deschambault, M | 1 |
| Lachance, R | 1 |
| Radouco-Thomas, S | 1 |
| Galambos, E | 2 |
| Pfeifer, AK | 2 |
| György, L | 1 |
| Molnár, J | 1 |
| Ostrovskaia, RU | 1 |
| Dill, RE | 1 |
| Nickey, WM | 1 |
| Little, MD | 1 |
| Blazsó, S | 1 |
| Michaelis, R | 1 |
10 reviews available for reserpine and Movement Disorders
| Article | Year |
|---|---|
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cytochrome P | 2010 |
[COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
Topics: Agranulocytosis; Autonomic Nervous System Diseases; Chemical and Drug Induced Liver Injury; Chlorpro | 1964 |
Effects of chronic administration of neuroleptics: dyskinesias in monkeys.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Butyrophenones; Depression, Chemical; Drug Toleranc | 1976 |
Drug-induced parkinsonism and other movement disorders.
Topics: Haloperidol; Humans; Movement Disorders; MPTP Poisoning; Parkinson Disease, Secondary; Phenothiazine | 1990 |
The biochemistry of dyskinesias.
Topics: Acetylcholine; Animals; Catecholamines; Cats; Copper; Dihydroxyphenylalanine; Dogs; Hepatolenticular | 1967 |
Pathological aspects on Parkinson's syndrome.
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Central Nervous System; Chlorpromazine; Corpus Stria | 1972 |
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopa | 1972 |
Persistent dyskinesia.
Topics: Age Factors; Brain Damage, Chronic; Central Nervous System Diseases; Dopamine; Female; Humans; Male; | 1973 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinic | 1967 |
Parkinson's disease. II.
Topics: Basal Ganglia; Catecholamines; Dihydroxyphenylalanine; Gait; Humans; Mental Processes; Movement Diso | 1970 |
3 trials available for reserpine and Movement Disorders
| Article | Year |
|---|---|
Treatment of drug-induced dyskinesias.
Topics: Aged; Dihydroxyphenylalanine; Humans; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease | 1970 |
[Extrapyramidal symptoms during the use of neuroleptics].
Topics: Butyrophenones; Central Nervous System Stimulants; Clinical Trials as Topic; Extrapyramidal Tracts; | 1967 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinic | 1967 |
83 other studies available for reserpine and Movement Disorders
| Article | Year |
|---|---|
Effect of Hypericum perforatum on different models of movement disorders in rats.
Topics: Animals; Disease Models, Animal; Fluphenazine; Hypericum; Male; Mastication; Motor Activity; Movemen | 2013 |
(-) Epigallocatechin-3-gallate attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum.
Topics: Animals; Catalase; Catechin; Corpus Striatum; Disease Models, Animal; Glutathione; Lipid Peroxidatio | 2015 |
Magnesium Supplementation Prevents and Reverses Experimentally Induced Movement Disturbances in Rats: Biochemical and Behavioral Parameters.
Topics: Animals; Brain; Disease Models, Animal; Erythrocytes; Lipid Peroxidation; Magnesium; Male; Movement | 2015 |
Physical exercise improves motor and short-term social memory deficits in reserpinized rats.
Topics: Analysis of Variance; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Male | 2009 |
Effect of Hibiscus rosa sinensis on reserpine-induced neurobehavioral and biochemical alterations in rats.
Topics: Animals; Antioxidants; Behavior, Animal; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Hi | 2009 |
Short term dietary fish oil supplementation improves motor deficiencies related to reserpine-induced parkinsonism in rats.
Topics: Animals; Catalepsy; Dietary Supplements; Disease Models, Animal; Fish Oils; Male; Movement Disorders | 2011 |
Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract.
Topics: Animals; Basal Ganglia Diseases; Carya; Catalepsy; Disease Models, Animal; Haloperidol; Male; Moveme | 2011 |
Ethanolic extract of Rubia peregrina L. (Rubiaceae) inhibits haloperidol-induced catalepsy and reserpine-induced orofacial dyskinesia.
Topics: Animals; Catalepsy; Ethanol; Haloperidol; Male; Movement Disorders; Plant Extracts; Rats; Reserpine; | 2012 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Systematic neuroleptic therapy with the appearance of parkinsonian states].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement Disorders; Reserpine | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Movement Disorders; | 1956 |
[Serpasil treatment of extrapyramidal hyperkinesia].
Topics: Humans; Hyperkinesis; Movement Disorders; Reserpine | 1956 |
[Serpasil treatment of extrapyramidal hyperkinesia].
Topics: Humans; Hyperkinesis; Movement Disorders; Reserpine | 1956 |
[Serpasil treatment of extrapyramidal hyperkinesia].
Topics: Humans; Hyperkinesis; Movement Disorders; Reserpine | 1956 |
[Serpasil treatment of extrapyramidal hyperkinesia].
Topics: Humans; Hyperkinesis; Movement Disorders; Reserpine | 1956 |
Effects of reserpine in animals, especially primates.
Topics: Animals; Catalepsy; Movement Disorders; Primates; Reserpine | 1956 |
[Reserpine treatment of certain forms of hyperkinesia in children; report on 20 cases].
Topics: Child; Humans; Hyperkinesis; Infant; Movement Disorders; Reserpine | 1957 |
[Experiences with reserpine in the treatment of agitated & overactive children & adolescents].
Topics: Child; Humans; Infant; Movement Disorders; Psychology, Child; Psychomotor Agitation; Reserpine | 1958 |
[Therapeutic value of extra-pyramidal symptoms in chlorpromazine & reserpine therapy].
Topics: Chlorpromazine; Extrapyramidal Tracts; Handwriting; Humans; Movement Disorders; Reserpine | 1958 |
HYPERMOTILITY EVOKED BY LESIONS OF THE SEPTUM AND ANTERIOR HYPOTHALAMUS.
Topics: Aminopyrine; Amygdala; Atropine; Body Temperature; Caudate Nucleus; Cerebral Ventricles; Chlorpromaz | 1963 |
EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS.
Topics: Adolescent; Chorea; Dystonia Musculorum Deformans; Dystonic Disorders; Genetic Diseases, X-Linked; H | 1963 |
[ON THE TREATMENT OF EXTRAPYRAMIDAL HYPERKINESIA WITH A NEW RESERPINE DERIVATIVE (RESEPINE ASCORBINATE)].
Topics: Ascorbic Acid; Athetosis; Chorea; Encephalitis; Extrapyramidal Tracts; Humans; Hyperkinesis; Movemen | 1963 |
THE EFFECT OF L-3, 4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE.
Topics: 5-Hydroxytryptophan; Amino Acids; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Inulin; Movement | 1964 |
[ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].
Topics: Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Handwriting; Humans; Movement Disorders; | 1964 |
AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.
Topics: Brain; Brain Damage, Chronic; Brain Diseases; Chlorpromazine; Chorea; Diagnosis, Differential; Elect | 1964 |
URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
Topics: Autonomic Nervous System Diseases; Chlorpromazine; Drug Therapy; Extrapyramidal Tracts; Fluids and S | 1965 |
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsych | 2005 |
Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
Topics: Animals; Behavior, Animal; Brain Chemistry; Carbamates; Catecholamines; Dihydroxyphenylalanine; Dopa | 1967 |
The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat.
Topics: Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; In Vitro Techni | 2000 |
Rapid-eye-movement sleep in jittery infants.
Topics: Female; Haloperidol; Humans; Infant; Male; Maternal-Fetal Exchange; Methyldopa; Movement Disorders; | 2002 |
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; H | 1977 |
Therapeutic response in hemiballismus.
Topics: Aged; Female; Haloperidol; Humans; Movement Disorders; Remission, Spontaneous; Reserpine | 1979 |
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Catecholamines; Chemical Phenomena; Chemistry; Dihy | 1978 |
Treatment with hemiballism with reserpine.
Topics: Humans; Male; Middle Aged; Movement Disorders; Reserpine | 1978 |
Stereotaxic lesions and movement disorders in monkeys.
Topics: Animals; Brain; Brain Mapping; Butyrophenones; Catalepsy; Catatonia; Cerebellum; Chorea; Haplorhini; | 1975 |
Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Dopamine beta-Hydroxylase; Imidazoles | 1975 |
Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
Topics: Amygdala; Animals; Apomorphine; Behavior; Brain; Corpus Striatum; Drug Synergism; Hippocampus; Human | 1975 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloper | 1976 |
Tardive dyskinesia.
Topics: Choline; Deanol; Dopamine Antagonists; Haloperidol; Humans; Methyldopa; Movement Disorders; Papaveri | 1976 |
Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility.
Topics: Adenosine; alpha-Methyltyrosine; Animals; Caffeine; Catecholamines; Dose-Response Relationship, Drug | 1991 |
L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's disease.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Female; Hydroxydopamines; Levodopa; Male; Mice; M | 1987 |
Chronic beta-adrenergic stimulation increases in mice the sensitivity to methysergide and the number of cerebral high affinity serotonin binding sites (5-HT-1).
Topics: Animals; Binding Sites; Brain; Clenbuterol; Drug Synergism; Ethanolamines; Male; Methysergide; Mice; | 1986 |
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Levodop | 1987 |
Toxicity and neuropharmacology of cyclopiazonic acid.
Topics: Animals; Body Weight; Chlorpromazine; Electrocardiography; Electroencephalography; Heart Rate; Hexob | 1985 |
Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Topics: Acetylcholine; Amphetamine; Animals; Cats; Corpus Striatum; Disease Models, Animal; Dopamine; Fronta | 1974 |
Alpha-rigidity in reserpinized rats.
Topics: Animals; Dihydroxyphenylalanine; Electromyography; Electrophysiology; Movement Disorders; Muscle Spi | 1964 |
[Experimental findings and new aspects in extrapyramidal diseases].
Topics: 5-Hydroxytryptophan; Blood Pressure; Body Temperature Regulation; Chorea; Dihydroxyphenylalanine; Do | 1966 |
Reserpine rigidity in the rat--a model for the analysis of antiparkinson drugs.
Topics: 1-Propanol; Animals; Biperiden; Cerebral Decortication; Electromyography; Methamphetamine; Models, N | 1968 |
Depression by antiparkinson drugs of reserpine rigidity.
Topics: 1-Propanol; Animals; Biperiden; Cyclohexanes; Depression, Chemical; Electromyography; Methamphetamin | 1968 |
Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Cyclohexanes; Cyclopentanes; Depression, Chemical; Dihydro | 1969 |
[Reserpine-parkinsonoid syndrome in the chimpanzee and its treatment with fencamfamin].
Topics: Animals; Antidepressive Agents; Catatonia; Hominidae; Humans; Movement Disorders; Parkinson Disease; | 1968 |
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyogr | 1969 |
[Specific therapy of extrapyramidal-motor syndromes].
Topics: Analgesics; Athetosis; Chorea; Datura stramonium; Dihydroxyphenylalanine; Dystonia Musculorum Deform | 1969 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus | 1972 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; My | 1973 |
Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.
Topics: Amphetamine; Animals; Apomorphine; Brain; Butyrophenones; Dopamine; Electrocoagulation; Haloperidol; | 1971 |
Drug-induced syndromes in rats with large, chronic lesions in the corpus striatum.
Topics: Amphetamine; Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Brain; Globus Pallidus; Haloperi | 1972 |
Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid.
Topics: Amphetamine; Animals; Catecholamines; Chlorine; Depression; Drug Antagonism; Drug Synergism; Humans; | 1967 |
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
Topics: Adult; Aged; Brain Damage, Chronic; Cheek; Chlorpromazine; Chlorprothixene; Clopenthixol; Female; Ha | 1967 |
Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey.
Topics: Animals; Catatonia; Cerebellum; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine; Haplorhini; Human | 1971 |
Drugs and motor functions.
Topics: Athetosis; Catecholamines; Cholinesterase Inhibitors; Chorea; Dihydroxyphenylalanine; Dopamine; Extr | 1971 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid | 1972 |
Mediocre effects of reserpine on tardive dyskinesia.
Topics: Adult; Female; Humans; Middle Aged; Movement Disorders; Reserpine | 1973 |
Reserpine: cause and treatment of oral-facial dyskinesia.
Topics: Deglutition Disorders; Diazepam; Face; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged | 1973 |
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose | 1974 |
Role of noradrenaline in levodopa reversal of reserpine akinesia.
Topics: Animals; Chlorpromazine; Dihydroxyphenylalanine; Haloperidol; Mice; Movement Disorders; Norepinephri | 1974 |
Reserpine for tardive dyskinesia.
Topics: Humans; Movement Disorders; Phytotherapy; Plants, Medicinal; Rauwolfia; Reserpine | 1972 |
[Drug-induced Parkinson's syndrome].
Topics: Acetylcholinesterase; Antiparkinson Agents; Dihydroxyphenylalanine; Dopamine; Humans; Movement Disor | 1972 |
The rabbit syndrome. A peculiar extrapyramidal reaction.
Topics: Aged; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Fatigue; Female; Humans; Male; M | 1972 |
Reserpine for tardive dyskinesia.
Topics: Humans; Movement Disorders; Reserpine | 1972 |
Drug-induced movement disorders.
Topics: Amphetamine; Contraceptives, Oral; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Female; Hu | 1971 |
Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
Topics: Animals; Behavior, Animal; Benzyl Compounds; Brain Chemistry; Dihydroxyphenylalanine; Dopa Decarboxy | 1971 |
Reserpine therapy of phenothiazine induced dyskinesia.
Topics: Adjustment Disorders; Aged; Female; Humans; Hypotension, Orthostatic; Male; Movement Disorders; Phen | 1971 |
Turning behaviour as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones.
Topics: Amphetamine; Animals; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Dopamine; Ephedrine; Explo | 1971 |
Reversal of the reserpine syndrome with L-dopa metabolites in reserpinized rats.
Topics: Animals; Central Nervous System; Dihydroxyphenylalanine; Motor Skills; Movement Disorders; Normetane | 1971 |
Sensitivity studies of L-dopa metabolites in reserpinized rats and their clinical significance.
Topics: Animals; Brain; Catechols; Dihydroxyphenylalanine; Female; Humans; Male; Mandelic Acids; Middle Aged | 1971 |
Psychoactive agents in dogs with bilateral lesions in subcortical structures.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Caudate Nucleus; Dogs; Movement Disorders; Quinoline | 1968 |
Psychoactive agents in dogs with bilateral lesions in subcortical structures.
Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Chlorpromazine; Dogs; Dopamine; Haloperidol; Hippocam | 1971 |
[Therapeutic findings in hemiballism and hemichorea].
Topics: Adolescent; Aged; Chorea; Electroencephalography; Female; Humans; Movement Disorders; Reserpine | 1969 |
[Attempt at treatment of permanent type of post-neuroleptic dyskinesia].
Topics: Aged; Female; Humans; Male; Methyldopa; Middle Aged; Movement Disorders; Reserpine; Tranquilizing Ag | 1970 |
[Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
Topics: Animals; Calcium; Calcium Metabolism Disorders; Depression, Chemical; Dihydroxyphenylalanine; Dopami | 1970 |
Study on the excitation induced by amphetamine, cocaine and alpha-methyltryptamine.
Topics: Amphetamine; Animals; Atropine; Benactyzine; Central Nervous System; Chlorpromazine; Cocaine; Mice; | 1967 |
Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
Topics: Animals; Brain; Crowding; Dopamine; Fever; Mice; Movement Disorders; Nialamide; Norepinephrine; Parg | 1967 |
[The basic pharmacologic properties of several 2-substituted tryptamines].
Topics: Animals; Brain; Cerebral Cortex; Electroencephalography; Mice; Movement Disorders; Rabbits; Rats; Re | 1967 |
Dyskinesia in rats following chemical stimulation of the neostriatum.
Topics: Animals; Carbachol; Dopamine; Extrapyramidal Tracts; Male; Motor Activity; Movement Disorders; Norep | 1968 |
[On the pharmacotherapeutic treatment of cerebral palsy. I. Treatment of movement disorders].
Topics: Cerebral Palsy; Child; Child, Preschool; Chlorpromazine; Humans; Infant; Infant, Newborn; Mephenesin | 1965 |
[Tetany, hysterical attack or side-effect of therapy?].
Topics: Adolescent; Adult; Female; Humans; Movement Disorders; Reserpine; Tetany; Tranquilizing Agents; Trif | 1966 |